25395. Adulteration and misbranding of barbital tablets, cinchophen tablets, 
phenobarbital tablets, and sugar-coated strychnine sulphate tablets. 
IJ. S. v. Hance Bros. & White, Inc. Plea of guilty. Defendant placed 
upon probation for 1 year. (F. & D. no. 35968. Sample nos. 18059-B, 
18067-B, 18068-B, 18081-B, 18099-B.)
These articles did not conform to the standard under which they were sold 
and their labels bore erroneous statements as to the quantities of their essential 
ingredients, respectively.
On September 18, 1935, the United States attorney for the Eastern District 
of Pennsylvania, acting upon a report by the Secretary of Agriculture, filed in 
the district court an information against Hance Bros. & White, Inc., Phila- 
delphia, Pa., alleging shipment in violation of the Food and Drugs Act as 
amended, on or about August 24, 1934, from Philadelphia, Pa., to Lambert- 
ville, N. J., of quantities of Compressed Tablets Barbital, Compressed Tablets 
Cincophen, Compressed Tablets Phenobarbital and Sugar-Coated Tablets, Strych- 
nine Sulph., which were adulterated and misbranded. The articles were labeled 
in part: (Bottle) "Compressed Tablets Barbital 5 Grains"; (bottle) "Com- 
pressed Tablets Cincophen 5 Grains" and on another bottle "Compressed Tablets 
Cincophen 7^ Grains"; (bottle) "Compressed Tablets Phenobarbital 1% 
Grains"; (bottle) "Sugar-Coated Tablets Strychnine Sulph. 1/40 Grain Hance 
Bros. & White Incorporated Pharmaceutical Chemists Philadelphia Estab. 1855."
Analyses showed the barbital tablets contained 4.41 grains of barbital, corre- 
sponding to a shortage of 11.8 percent of the declared 5-grain tablet; that the 
5-grain cinchophen tablets contained 4.37 grains of cinchophen, corresponding to 
a shortage of 12.6 percent of the declared 5-grain tablet; that the 7%-grain 
cinchophen tablets contained 6.43 grains of cinchophen, corresponding to a short- 
age of 14.3 percent of the declared 7 grain tablet; that the 1 grain pheno- 
barbital tablets contained 1.36 grains of phenobarbital, corresponding to a 
shortage of 9.3 percent of the declared 1%-grain tablet; that the sugar-coated 
strychnine sulphate tablets (1/40-grain) contained 0.021 grain of strychnine 
sulphate, corresponding to a shortage of 16 percent of the declared 1/40-grain 
tablet.
The barbital tablets were alleged to be adulterated in that their strength 
and purity fell below the professed standard and quality under which they 
were sold, in that each tablet contained not more than 4.41 grains of barbital.
The cinchophen tablets were alleged to be adulterated In that their strength 
and purity fell below the professed standard and quality under which they 
were sold, with respect to the quantity thereof contained in the bottles which 
were labeled "Cincophen 5 Grains", in that each of said tablets contained not 
more than 4.37 grains of cinchophen, with respect to the bottles which were 
labeled "Cincophen 7% Grains", that each of said tablets contained not more 
than 6.43 grains of cinchophen.
The phenobarbital tablets were alleged to be adulterated in that their strength 
and purity fell below the professed standard and quality under which they were 
sold, in that each tablet contained not more than 1.36 grains of phenobarbital.
The sugar-coated strychnine sulphate tablets were alleged to be adulterated 
in that their strength and purity fell below the professed standard and quality 
under which they were sold in that each of said tablets contained not more than 
0.021 grain (1/48 grain) of strychnine sulphate.
The barbital tablets were alleged to be misbranded in that the statement borne 
on the bottle containing the article, to wit, "Tablets Barbital 5 Grains", was false 
and misleading, in that said tablets contained not more than 4.41 grains of 
barbital.
The cinchophen tablets were alleged to be misbranded In that the statement 
borne on one of said bottles containing said article, to wit, "Tablets Cincophen 5 
Grains", was false and misleading in that said tablets contained not more than 
4.37 grains of cinchophen, and in that the statement borne on the other of said 
bottles, to wit, "Tablets Cincophen 7% Grains", was false and misleading in that 
the said tablets contained not more than 6.43 grains of cinchophen.
The phenobarbital tablets were alleged to be misbranded in that the state- 
ment borne on the bottle, to wit, "Tablets Phenobarbital 1^ Grains", was false 
and misleading in that each of said tablets contained not more than 1.36 grains 
of phenobarbital.
The sugar-coated strychnine sulphate tablets were alleged to be misbranded 
in that the statement borne on the bottle, to wit, "Tablets Strychnine Sulph. 1/40
Grain", was false and misleading, in that each of said tablets contained not more 
than 0.021 grain (1/48 grain) of strychnine sulphate.
On December 2, 1935, a plea of nolo contendere having been entered, the 
defendant was placed upon probation for 1 year.
M. L. WILSON, Acting Secretary of Agriculture.